Kari Kervinen

15.1k citations

82 papers · 3.5k indexed · h-index 34

Surgery top 2%
Physiology top 2%
Endocrinology, Diabetes and Metabolism top 1%
Cardiology and Cardiovascular Medicine top 2%
Molecular Biology

Co-authors: Markku J. Savolainen Y. Antero Kesäniemi Markku Laakso Keijo Koivisto Tuomo Hänninen Matti Vanhanen Johanna Kuusisto Leena Mykkänen
Topics: Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers)Lipoproteins and Cardiovascular Health (20 papers)Coronary Interventions and Diagnostics (20 papers)
Cited by: Endocrinology, Diabetes and Metabolism Physiology Cardiology and Cardiovascular Medicine
Journals: Circulation Gastroenterology American Journal of Clinical Nutrition
Partner nations: Finland United Kingdom Spain

In The Last Decade

Kari Kervinen

79 papers receiving 3.4k citations

Peers

Countries citing papers authored by Kari Kervinen

Since Specialization

Citations

This map shows the geographic impact of Kari Kervinen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kari Kervinen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kari Kervinen more than expected).

Fields of papers citing papers by Kari Kervinen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kari Kervinen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kari Kervinen. The network helps show where Kari Kervinen may publish in the future.

Co-authorship network of co-authors of Kari Kervinen

This figure shows the co-authorship network connecting the top 25 collaborators of Kari Kervinen. A scholar is included among the top collaborators of Kari Kervinen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kari Kervinen. Kari Kervinen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Titanium-nitride-oxide-coated vs. drug-eluting stents in acute coronary syndromes: an individual patient data meta-analysis 2025 ·European Heart Journal ·Thabo Mahendiran,Frédéric Bouisset,Pim A.L. Tonino,Nico H.J. Pijls,Jussi Sia,Kari Kervinen,(unknown),Peter Jüni,Bruno R. da Costa,(unknown),Takuya Mizukami,Pasi P. Karjalainen,Bernard De Bruyne	0
2	Titanium-Nitride-Oxide–Coated Versus Everolimus-Eluting Stents in Acute Coronary Syndrome 2020 ·JACC: Cardiovascular Interventions ·Pim A.L. Tonino,Nico H.J. Pijls,Carlos Collet,Wail Nammas,Jan Van der Heyden,Hannu Romppanen,Kari Kervinen,Juhani Airaksinen,Jussi Sia,Jacques Lalmand,Peter Frambach,Antonio Serra Peñaranda,Bernard De Bruyne,Pasi P. Karjalainen	25
3	Intravascular ultrasound assessment of minimum lumen area and intimal hyperplasia in in-stent restenosis after drug-eluting or bare-metal stent implantation. The Nordic Intravascular Ultrasound Study (NIVUS) 2017 ·Cardiovascular revascularization medicine ·Lisette Okkels Jensen,Saila Vikman,Lisbeth Antonsen,(unknown),Matti Niemelä,Evald Høj Christiansen,Kari Kervinen,Andrejs Ērglis,Jan Harnek,Indulis Kumsārs,Leif Thuesen,Kari Niemelä	15
4	Five-year clinical outcome of titanium-nitride-oxide-coated bioactive stents versus paclitaxel-eluting stents in patients with acute myocardial infarction: Long-term follow-up from the TITAX AMI trial 2012 ·International Journal of Cardiology ·Petri Tuomainen,Antti Ylitalo,Matti Niemelä,Kari Kervinen,Mikko Pietilä,Jussi Sia,Kai Nyman,Wail Nammas,Juhani Airaksinen,Pasi P. Karjalainen	37
5	Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction 2009 ·Annals of Medicine ·Pasi P. Karjalainen,Antti Ylitalo,Matti Niemelä,Kari Kervinen,Timo Mäkikallio,Mikko Pietilä,Jussi Sia,Petri Tuomainen,Kai Nyman,Juhani Airaksinen	24
6	Determinants of functional recovery after myocardial infarction of patients treated with bone marrow-derived stem cells after thrombolytic therapy 2009 ·Heart ·Johanna A. Miettinen,Kari Ylitalo,Pär Hedberg,Jari Jokelainen,Kari Kervinen,Marjo Niemelä,Marjaana Säily,P. Koistinen,Eeva‐Riitta Savolainen,Heikki Ukkonen,Mikko Pietilä,Juhani Airaksinen,Juhani Knuuti,Olli Vuolteenaho,Timo Mäkikallio,Heikki V. Huikuri	30
7	Risk of dementia associated with the ApoE ɛ4 allele and falls causing head injury without explicit traumatic brain injury 2008 ·Acta Neurologica Scandinavica ·Heikki Luukinen,Jari Jokelainen,Kari Kervinen,Y. Antero Kesäniemi,Satu Winqvist,Matti Hillbom	11
8	INTERLEUKIN-6 PROMOTER POLYMORPHISM AND LATE-ONSET ALZHEIMER's DISEASE IN THE FINNISH POPULATION 2005 ·Journal of Neurogenetics ·Anne M. Koivisto,Seppo Helisalmi,Jussi Pihlajamäki,Leena Moilanen,Johanna Kuusisto,Markku Laakso,Mikko Hiltunen,(unknown),Tuomo Hänninen,Eeva‐Liisa Helkala,Kari Kervinen,Y. Antero Kesäniemi,Hilkka Soininen	23
9	Apolipoprotein E polymorphism affects carotid artery atherosclerosis in smoking hypertensive men 2002 ·Journal of Hypertension ·Jarkko Karvonen,Heikki Kauma,Kari Kervinen,Olavi Ukkola,Maire Rantala,M. Pãivänsalo,Markku J. Savolainen,Y. Antero Kesäniemi	39
10	The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjects 1999 ·Gut ·(unknown),Kari Kervinen,Asko O. Rantala,Heikki Kauma,M. Pãivänsalo,Markku J. Savolainen,Mauno Lilja,Y. Antero Kesäniemi	30
11	The effect of the apolipoprotein E phenotype on cholesteryl ester transfer protein activity, plasma lipids and apolipoprotein A I levels in hypercholesterolaemic patients on colestipol and lovastatin treatment 1999 ·European Journal of Clinical Pharmacology ·T K Korhonen,Minna L. Hannuksela,(unknown),Kari Kervinen,Y. Antero Kesäniemi,M.J. Savolainen	15
12	Social alcohol consumption and low Lp(a) lipoprotein concentrations in middle aged Finnish men: population based study 1998 ·BMJ ·Marita Paassilta,Kari Kervinen,Asko O. Rantala,Markku J. Savolainen,Mauno Lilja,Antti Reunanen,Y. Antero Kesäniemi	39
13	Association between features of the insulin resistance syndrome and alzheimer's disease independently of apolipoprotein e4 phenotype: cross sectional population based study 1997 ·BMJ ·Johanna Kuusisto,Keijo Koivisto,Leena Mykkänen,E.-L. Helkala,Matti Vanhanen,Tuomo Hänninen,Kari Kervinen,Y. Antero Kesäniemi,Paavo Riekkinen,Markku Laakso	354
14	Apolipoprotein E phenotype and diet-induced alteration in blood pressure 1997 ·American Journal of Clinical Nutrition ·Maire Rantala,(unknown),Kari Kervinen,Y. Antero Kesäniemi	12
15	Lathosterol and other non-cholesterol sterols during treatment of hypercholesterolaemia with beta-glucan-rich oat bran 1997 ·European Journal of Clinical Nutrition ·MIJ Uusitupa,T.A. Miettinen,ES Sarkkinen,(unknown),Kari Kervinen,Y. Antero Kesäniemi	26
16	Memory functions in human subjects with different apolipoprotein E phenotypes during a 3-year population-based follow-up study 1996 ·Neuroscience Letters ·E.-L. Helkala,Keijo Koivisto,Tuomo Hänninen,Matti Vanhanen,Kari Kervinen,Johanna Kuusisto,Leena Mykkänen,Y. Antero Kesäniemi,Markku Laakso,Paavo Riekkinen	80
17	Is the development of adenoma and carcinoma in proximal colon related to apolipoprotein E phenotype? 1996 ·Gastroenterology ·Kari Kervinen,(unknown),Jyrki Mäkelä,J. Lehtola,(unknown),(unknown),Y. Antero Kesäniemi	54
18	Association of apolipoprotein E phenotypes with late onset Alzheimer's disease: population based study 1994 ·BMJ ·Johanna Kuusisto,Keijo Koivisto,Kari Kervinen,Leena Mykkänen,E.-L. Helkala,Matti Vanhanen,Tuomo Hänninen,K Pyörälä,Y. Antero Kesäniemi,Paavo Riekkinen,(unknown)	177
19	Apolipoprotein E and B polymorphisms - longevity factors assessed in nonagenarians 1994 ·Atherosclerosis ·Kari Kervinen,Markku J. Savolainen,Juhani Salokannel,(unknown),(unknown),(unknown),M. Juhani Koistinen,Y. Antero Kesäniemi	124
20	Gallstone cholesterol content is related to apolipoprotein E polymorphism 1993 ·Gastroenterology ·Tatu Juvonen,Kari Kervinen,Matti I. Kairaluoma,Lauri H. J. Lajunen,Y. Antero Kesäniemi	64

About Kari Kervinen

Kari Kervinen is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery, having authored 82 papers that have together received 3.5k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (23 papers), Lipoproteins and Cardiovascular Health (20 papers) and Coronary Interventions and Diagnostics (20 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (938 citations), Physiology (1.0k citations) and Cardiology and Cardiovascular Medicine (726 citations). Kari Kervinen has collaborated with scholars based in Finland, United Kingdom and Spain. Frequent co-authors include Markku J. Savolainen, Y. Antero Kesäniemi, Markku Laakso, Y. Antero Kesäniemi, Keijo Koivisto, Tuomo Hänninen, Matti Vanhanen, Johanna Kuusisto, Leena Mykkänen and Y. Antero Kesäniemi. Their work appears in journals such as Circulation, Gastroenterology and American Journal of Clinical Nutrition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact